Lotte M Knapen

Lotte M Knapen

UNVERIFIED PROFILE

Are you Lotte M Knapen?   Register this Author

Register author
Lotte M Knapen

Lotte M Knapen

Publications by authors named "Lotte M Knapen"

Are you Lotte M Knapen?   Register this Author

6Publications

104Reads

17Profile Views

Development and validation of an analytical method using UPLC-MS/MS to quantify everolimus in dried blood spots in the oncology setting.

J Pharm Biomed Anal 2018 Feb 29;149:106-113. Epub 2017 Oct 29.

Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center+, P.O. BOX 5800, 6202 AZ, Maastricht, The Netherlands; CAPHRI-Care And Primary Health Research Institute, Maastricht University Medical Center+, P.O. BOX 616, 6200 MD, Maastricht, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S07317085173168
Publisher Site
http://dx.doi.org/10.1016/j.jpba.2017.10.039DOI Listing
February 2018

Use of incretin agents and risk of acute and chronic pancreatitis: A population-based cohort study.

Diabetes Obes Metab 2017 03 7;19(3):401-411. Epub 2017 Feb 7.

Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre+, Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.12833DOI Listing
March 2017

Plasma concentrations of tyrosine kinase inhibitors imatinib, erlotinib, and sunitinib in routine clinical outpatient cancer care.

Ther Drug Monit 2014 Jun;36(3):326-34

*Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam, the Netherlands; †Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; and ‡Division of Pharmaco-epidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00007691-201406000-000
Publisher Site
http://dx.doi.org/10.1097/FTD.0000000000000004DOI Listing
June 2014

Thiazolodinediones and cancer: duplicate publication bias?

Oncologist 2013 ;18(10):1147

Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre+, Maastricht, The Netherlands;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2013-0087DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805158PMC
May 2014

Use of biguanides and the risk of colorectal cancer: a register-based cohort study.

Curr Drug Saf 2013 Nov;8(5):349-56

Maastricht University Medical Centre, Department of Clinical Pharmacy and Toxicology, P. Debyelaan 25, 6228 HX Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
November 2013